Short answer
TriSalus Life Sciences, Inc. (TLSI) filed an 8-K current report with the SEC on September 22, 2026 reporting Item 8.01 (Other Events). FDA 510(k) clearance received for TriNav Advance, removing a key U.S. regulatory barrier.
TriSalus Life Sciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- FDA 510(k) clearance received for TriNav Advance, removing a key U.S. regulatory barrier
- Commercialization expected to commence, creating potential revenue opportunity for TriSalus
- Press release attached as Exhibit 99.1 with product and launch details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TriSalus Life Sciences, Inc. 8-K filings
Get the next TLSI 8-K as it lands
Follow TLSI for push alerts, or ask the research agent what this filing means.